CRISPR-/Cas9 based genome editing for treating genetic disorders and diseases / editor, Luis María Vaschetto, Oncativo, Córdoba, Argentina.
Material type:
- 9780367542863
- 9780367542870
- 572.88078 VAS 23
Item type | Current library | Home library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
Dept. of Bio-Technology | Dept. of Bio-Technology | 572.88078 VAS (Browse shelf(Opens below)) | Available | BTY3364 |
"A Science Publishers book."
Includes bibliographical references and index.
"The field of genome editing has progressed incredibly in the last few years mainly due to the emergence of versatile genome editing tools such as endonuclease-based systems which can be used to efficiently edit gene sequences in a targeted fashion. The CRISPR/Cas9 genome editing system represents an easy-to-use and low-cost alternative for gene editing that has revolutionized research in many different areas ranging from medicine and biotechnology, by democratizing genome editing in laboratories around the world. Remarkably, the CRISPR/Cas9-mediated gene editing system can be used to replace/correct nucleotide mutations associated with genetic disorders and diseases. The objective of this book is to shed light on the CRISPR/Cas9 system and related genome engineering technologies in therapeutics and gene therapy"--
There are no comments on this title.